105 related articles for article (PubMed ID: 12375663)
1. QTc prolongation in apheresis platelet donors.
Laspina SJ; Browne MA; McSweeney EN; Lawlor J; Whelan DM; Kinsella AL; Murphy WG
Transfusion; 2002 Jul; 42(7):899-903. PubMed ID: 12375663
[TBL] [Abstract][Full Text] [Related]
2. QTc prolongation during peripheral stem cell apheresis in healthy volunteers.
Korur A; Kozanoglu I; Buyukkurt N; Yeral M; Kandemir F; Gereklioglu C; Sariturk C; Asma S; Solmaz S; Boga C; Ozdogu H
J Clin Apher; 2017 Aug; 32(4):240-245. PubMed ID: 27543914
[TBL] [Abstract][Full Text] [Related]
3. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
4. Assessment of corrected QT interval in sickle-cell disease patients who undergo erythroapheresis.
Boga C; Kozanoglu I; Yeral M; Bakar C
Transfus Med; 2007 Dec; 17(6):466-72. PubMed ID: 18067651
[TBL] [Abstract][Full Text] [Related]
5. High-Fidelity Analysis of Perioperative QTc Prolongation.
Duma A; Pal S; Helsten D; Stein PK; Miller JP; Nagele P
Anesth Analg; 2016 Feb; 122(2):439-48. PubMed ID: 26505572
[TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms.
Bolan CD; Wesley RA; Yau YY; Cecco SA; Starling J; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1403-13. PubMed ID: 14507272
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
[TBL] [Abstract][Full Text] [Related]
8. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
9. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
Mercan D; Bastin G; Lambermont M; Dupont E
Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage.
Fukui S; Katoh H; Tsuzuki N; Ishihara S; Otani N; Ooigawa H; Toyooka T; Ohnuki A; Miyazawa T; Nawashiro H; Shima K
Crit Care; 2003 Jun; 7(3):R7-R12. PubMed ID: 12793884
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
12. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.
Ackerman MJ; Khositseth A; Tester DJ; Hejlik JB; Shen WK; Porter CB
Mayo Clin Proc; 2002 May; 77(5):413-21. PubMed ID: 12004990
[TBL] [Abstract][Full Text] [Related]
13. Severe citrate toxicity complicating volunteer apheresis platelet donation.
Bell AM; Nolen JD; Knudson CM; Raife TJ
J Clin Apher; 2007 Feb; 22(1):15-6. PubMed ID: 17111419
[TBL] [Abstract][Full Text] [Related]
14. Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.
Poole SA; Pecoraro A; Subramaniam G; Woody G; Vetter VL
J Addict Med; 2016; 10(1):26-33. PubMed ID: 26690291
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
[TBL] [Abstract][Full Text] [Related]
16. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
Chang KC; Huang CL; Liang HY; Chang SS; Wang YC; Liang WM; Lane HY; Chen CH; Stephen Huang SK
J Cardiovasc Electrophysiol; 2012 May; 23(5):527-33. PubMed ID: 22136144
[TBL] [Abstract][Full Text] [Related]
17. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
19. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
Vrtovec B; Knezevic I; Poglajen G; Sebestjen M; Okrajsek R; Haddad F
Am J Cardiol; 2013 Mar; 111(6):886-90. PubMed ID: 23273526
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for QTc interval prolongation.
Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
